Juno Bio Ltd.

Juno Bio is a private, early-revenue stage company founded in 2020 that operates in the women's health and microbiome diagnostics sector. Its core product is a comprehensive, at-home vaginal microbiome test that uses sequencing to identify all bacteria present, not just a select few. The business model combines DTC diagnostic services with a research platform, offering customers personalized insights and consultations while building a proprietary dataset to advance scientific understanding of vaginal health. The company is positioned to address a significant unmet need in a historically underfunded area of medicine.

Next-generation sequencing and bioinformatics platform for comprehensive vaginal microbiome analysis and aggregated research database.

Juno Bio competes with other DTC microbiome companies (e.g., Viome, Daye) and traditional clinical diagnostic labs. Its primary differentiation is the exclusive focus on the vaginal microbiome, comprehensive sequencing (vs. targeted PCR), and the integrated coaching service. It also faces potential competition from academic initiatives and large biopharma companies entering the women's health microbiome space.